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ABSTRACT: Combined mass spectrometry imaging methods in which two diﬀerent
techniques are executed on the same sample have recently been reported for a number of
sample types. Such an approach can be used to examine the sampling eﬀects of the ﬁrst
technique with a second, higher resolution method and also combines the advantages of each
technique for a more complete analysis. In this work matrix-assisted laser desorption ionization
mass spectrometry imaging (MALDI MSI) was used to study the eﬀects of liquid extraction
surface analysis (LESA) sampling on mouse brain tissue. Complementary multivariate analysis
techniques including principal component analysis, non-negative matrix factorization, and t-
distributed stochastic neighbor embedding were applied to MALDI MS images acquired from
tissue which had been sampled by LESA to gain a better understanding of localized tissue
washing in LESA sampling. It was found that MALDI MS images could be used to visualize
regions sampled by LESA. The variability in sampling area, spatial precision, and delocalization
of analytes in tissue induced by LESA were assessed using both single-ion images and images
provided by multivariate analysis.
Liquid extraction surface analysis (LESA) mass spectrom-etry oﬀers improved sensitivity through a combination of
eﬃcient analyte extraction and increase in the relative area
sampled. LESA involves use of a small droplet of solvent to
extract soluble analytes at the solid−liquid interface called the
liquid microjunction.1 In a traditional LESA experiment the
minimum pixel size is limited by the diameter of the solvent
droplet, ∼1 mm.1 Smaller pixel sizes may be achieved through a
modiﬁcation to the surface sampling routine whereby the pipet
tip makes contact with the sample surface and the pixel size is
limited by the diameter of the pipet tip.2,3 Brenton and Godfrey
have suggested alternative methods for the improvement of
spatial resolution possible by LESA mass spectrometry imaging
(MSI).4
LESA MS has been reported for detection of lipids, peptides,
proteins, drugs, and metabolites directly from thin tissue
sections under ambient conditions with no sample prepara-
tion.5−9 A further beneﬁt of LESA MS is the decoupling of
desorption and ionization events. This provides opportunities
for postextraction separation (for example, via HPLC),10
derivatization, or inclusion of internal standards for quantiﬁca-
tion.9 Electrospray ionization (ESI) can produce multiply
charged ions; therefore, mass analyzers with a limited mass-to-
charge ratio (m/z) range can be used and a wider range of
fragmentation techniques can be employed.
Through combining techniques such as matrix-assisted laser
desorption ionization (MALDI) and LESA, one can maximize
the advantages of each and use them in complement. Several
examples of such an approach exist in the literature: MALDI
MSI and LESA MS have been used on adjacent tissue sections
to study drug absorption into skin; LESA MS was used as a
veriﬁcation step to complement the MALDI MSI data.11
Quanico et al. used a MALDI MSI-guided approach to identify
regions of anatomical interest. These regions of an adjacent
section were then analyzed by LESA coupled to liquid
chromatography−mass spectrometry (LC−MS) for improved
sensitivity, resulting in more complete identiﬁcation of
proteins.9 Griﬃths et al. used MALDI MSI and LESA MS to
demonstrate that a sample preparation technique for improved
lipid analysis yielded similar results when two diﬀerent
ionization methods were employed.6 The potential for
inclusion of internal standards in LESA extraction solvents
was exploited by Tomlinson et al. who used LESA coupled to
nanoelectrospray ionization and LC−MS to investigate ion
suppression eﬀects in MALDI.12 Swales et al. demonstrated the
complementary capabilities of various MSI techniques includ-
ing MALDI MSI and LESA MS. They employed each on
adjacent sections of organs from cassette- and discrete-dosed
animals and compared their ability to detect four diﬀerent
target compounds.13 It is important to note that each of these
methods have employed MALDI MSI and LESA MS on
adjacent sections which are therefore nonidentical. This
increases the challenge when attempting to correlate, compare,
or combine the data acquired with each technique. Additionally,
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this would be impossible in situations where no adjacent
section is available.
Repeat analysis by MALDI MSI of a single tissue section was
reported by Steven and Bunch14 and Garrett et al.,15 who
demonstrated that multiple MSI data sets could be acquired
from a single sample, either by taking advantage of remaining
matrix after initial analysis or by addition of a tissue wash and
reapplication of matrix. These results show that reanalysis of
tissue samples is an avenue towards obtaining complementary
data. The importance of executing multimodal MSI workﬂows
on the same tissue section has been recognized in studies
seeking to combine other mass spectrometry techniques.
Eberlin et al. reported a method for combining desorption
electrospray ionization (DESI) MSI for lipid imaging, MALDI
MSI for protein imaging, and hematoxylin and eosin (H&E)
staining for morphological information on the same tissue
section.16 Eijkel et al. performed MALDI MSI and secondary
ion mass spectrometry (SIMS) imaging on the same tissue
section and outlined a workﬂow for correlating these data
sets.17
In addition to extracting more information about the content
of a sample, a number of “multimodal” studies have been
conducted with the aim of using one method to understand
another. Passarelli et al. reported time-of-ﬂight SIMS (TOF-
SIMS) imaging of matrix crystals prepared for use in MALDI
MS imaging experiments and determined crystal size, analyte
distribution, and delocalization of analytes upon matrix
addition. Korsgen et al. also report TOF-SIMS imaging of
analyte incorporation in matrix crystals prepared under
diﬀerent conditions, shedding light on the eﬀects of sample
preparation and leading to more optimal analysis.
As a relatively new technique LESA requires further study to
fully understand the sampling process. Recent work by Kertesz
and Van Berkel evaluated the reliability of liquid junction
formation, sampling precision, spatial resolution, and extraction
eﬃciency of a droplet-based extraction system with a simple
model sample (ink on glass).18 They found that, through
control of probe-to-surface distance, dispensation volume, and
aqueous solvent content, a stable liquid junction may be formed
with good spatial precision. The stability of a liquid junction
depends on sample surface properties such as wettability; this is
sample-dependent, and therefore, these conclusions may not
hold true when sampling tissue instead of glass.
Here we present the combination of MALDI and LESA for
analysis of lipids, drugs, and proteins in a single tissue section.
In this work MALDI MSI was used to image analyte
distributions in tissue, post-LESA and therefore indicated
how LESA sampling had altered the sample composition. This
experiment provided insight into aspects of LESA sampling
such as the area of tissue surveyed and variation and spatial
precision of sampling. Previously this has only been assessed
using optical images. Complementary multivariate analysis
techniques were applied to the MALDI MSI data to determine
spectral and spatial changes to the sample which occurred as a
result of LESA sampling. This analysis indicated how MALDI
spectra change as a result of LESA sampling.
■ EXPERIMENTAL SECTION
Materials. Ethanol, methanol, and formic acid were
purchased from Fisher Scientiﬁc (Leicestershire, U.K.).
Triﬂuoroacetic acid was purchased from Acros Organics. α-
Cyano-4-hydroxycinnamic acid (CHCA) matrix was purchased
from Sigma-Aldrich (Gillingham, U.K.), and glass slides were
from Thermo Scientiﬁc. Fresh frozen mouse brain tissue was
provided by Professor Steve Watson at the University of
Birmingham. Erlotinib was provided by Dr. Richard Goodwin
at AstraZeneca.
Tissue Sample Preparation. Mouse brain tissue was
sectioned (Leica CM 1850 cryostat, Milton Keynes, U.K.) at 10
μm thickness and thaw-mounted onto glass slides. The section
which was destined for imaging by LESA MS had 0.3 μL of 200
nM erlotinib solution (80/20 methanol/water) deposited at a
speciﬁc location (see text below).
Liquid Extraction Surface Analysis Mass Spectrome-
try. Surface sampling was performed using a TriVersa
Nanomate chip-based electrospray device (Advion, Ithaca,
NY). The electrospray device was coupled to a Thermo Fisher
Orbitrap Velos (Thermo Fisher Scientiﬁc, Bremen, Germany)
instrument. The robotic system was controlled through LESA
Points and ChipSoft 8.3.3 software. A glass slide with tissue
sections aﬃxed was mounted in the LESA universal adaptor
plate and scanned using an Epson ﬂatbed scanner. The scanned
image was imported into LESA Points, and the sampling
locations were deﬁned. A grid of 108 sampling locations was
selected with an x, y spacing of 1 mm, covering the whole tissue
section. The z coordinate was set to a height 0 mm relative to
the sample surface to allow the pipette tip to come into contact
with the sample (“contact” LESA). For “noncontact” LESA
experiments, the pipette tip descended to a height ∼0.2 mm
above the surface of the sample. The solvent system for
extraction and electrospray was methanol, water, and formic
acid (69.3:29.7:1). The robotic arm collected a conductive
pipet tip and aspirated 0.7 μL of solvent from the reservoir. The
arm relocated to the x, y coordinates speciﬁed by LESA Points
software. The pipette tip descended to the predetermined
height (see above) and dispensed 0.5 μL of solvent. The liquid
microjunction was maintained for 4 s before reaspiration. Each
sample was delivered for 1 min via the Triversa Nanomate with
a gas pressure of 0.3 psi and a tip voltage of 1.4 kV. Positive ion
mass spectra were acquired in full scan mode (m/z 150−2000)
at a resolution of 100 000 at m/z 400. The automatic gain
control was turned oﬀ, and the injection time ﬁxed at 100 ms.
Each scan was composed of ﬁve coadded microscans.
MALDI Mass Spectrometry Imaging. Mouse brain
sections were coated with CHCA matrix (5 mg/mL in 80%
MeOH, 0.1% TFA) using a TM-Sprayer (HTX Technologies,
LLC). Matrix was sprayed with a ﬂow rate 0.115 mL/min and
track speed of 1333 mm/min. The capillary temperature was 90
°C, and the spacing between tracks was 3 mm. Inspection of
microscope images revealed that eight cycles of this method,
with alternating rotation by 90° and 1.3 mm track oﬀset, was
found to produce relatively homogeneous sample coverage.
MALDI MS imaging was carried out on a QSTAR XL QqTOF
mass spectrometer (AB Sciex). An Elforlight (Daventry, U.K.)
Nd:YAG laser with λ = 355 nm was coupled to the MALDI
source via a 100 μm diameter ﬁber (OZ Optics Ltd.) and was
operated at a frequency of 1 kHz. The ﬂuence at the sample
surface was ∼120 J m−2. The sampling raster speed was 0.2
mm/s. Data were acquired in positive ion mode with a pixel
size of 100 μm × 100 μm or 50 μm × 50 μm.
Hematoxylin and Eosin Staining. H&E staining was
performed by Epistem according to standard protocols.
Optical Microscopy. Optical microscopy was performed
on a Pathscan Enabler IV slide scanner and an Olympus CX40
microscope ﬁtted with a 5× magniﬁcation objective lens.
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Image Generation. A separate RAW ﬁle was generated for
each LESA experiment (corresponding to a single pixel),
consisting of multiple scans. Data were converted from RAW to
mzML using msconvert as part of ProteoWizard.19 The mean
spectrum within a single mzML ﬁle (for each pixel) was
calculated and output to a new mzML ﬁle, resulting in a
spectrum per pixel. These were combined, along with the
spectra locations, into an imzML ﬁle using imzMLConverter to
produce an MS image.20
WIFF ﬁles generated by the QSTAR XL QqTOF mass
spectrometer were converted to mzML ﬁles using MS Data
Converter (AB Sciex). One mzML ﬁle was produced per raster
line of the image. These were converted to a single imzML ﬁle
using imzMLConverter.20
Data Analysis. Image ﬁles (imzML) were viewed and
processed using in-house software, running in MATLAB
(R2014b). Memory eﬃcient principal component analysis
(PCA) and k-means (k = 7) were applied as described by
Race et al.21 with the smoothing step in the preprocessing
workﬂow modiﬁed to dual-pass Savitzky−Golay (window size
of 11).
Principal component 1 and principal component 2 score
images were used in combination to generate a binary mask for
isolating the on-tissue spectra. MALDI MSI on tissue spectra
were further reduced by selecting peaks from the total spectrum
using a gradient-based method,21 using the modiﬁed
preprocessing workﬂow described above. NMF (k = 25.
MATLAB) and t-SNE22 were applied to the reduced data.
■ RESULTS AND DISCUSSION
LESA MS Imaging. An automated surface sampling routine
was deﬁned and implemented using the TriVersa Nanomate.
The locations selected for contact LESA sampling are
demonstrated in Figure 1a. Full scan mass spectra were
obtained from each sample location (for example, see Figure
1b). Here we demonstrate for the ﬁrst time that LESA MS is
able to detect multiple classes of analyte in a single extraction/
electrospray event. Peaks in the m/z range of 700−850
correspond to various phosphatidylcholine (PC) lipid ions,
preferentially detected as the protonated species. Ions detected
with m/z 734.5708, 760.5870, and 782.5703 are tentatively
assigned as protonated molecules of (PC) 32:0 (Δppm = 1.9),
(PC) 34:1 (Δppm = 2.5), and (PC) 36:4 (Δppm = 1.2),
respectively. Multiply charged protein ions predominantly
appear in the m/z range of 600−1200. Ions at m/z 857.3743
(charge state +10) are tentatively assigned as ubiquitin (Δppm
= 2.1), which has previously been detected from mouse brain
tissue using LESA MS.5 Other protein ions (unidentiﬁed) were
detected with charge states ranging between +7 and +22. The
tissue was spiked with 0.3 μL of 200 nM erlotinib solution, for
location of drug spike see Figure 1c. Taking into account the
area over which the droplet spread, we estimate that
approximately 4.8 fmol of erlotinib was present per 0.4 mm2
(the approximate area covered by a single contact LESA
extraction, more discussion to follow). The drug was detected
in every LESA spectrum sampled from this region. Example
LESA MS images are displayed in Figure 1d−h, indicating the
diﬀerent distributions of PC 34:1, ubiquitin, heme, and
erlotinib, across the tissue section. In this work we have
Figure 1. LESA MS of mouse brain tissue: (a) Locations selected for LESA sampling. (b) Example full scan LESA mass spectrum; peaks with m/z in
the range of 700−900 correspond to lipid ions; enlargements of peaks corresponding to erlotinib (m/z 394.1773) and ubiquitin (m/z 857.3743) are
shown the inset. (c) Circle indicates location selected for erlotinib deposition, covering both grey and white matter as indicated using H&E stained
reference. (d) LESA MS image of ions with m/z 184.0739 corresponding to the phosphatidylcholine lipid headgroup. (e) LESA MS image of ions
with m/z 760.5870 corresponding to [M + H]+ ions of PC 34:1. (f) LESA MS image of ions with m/z 616.1782 corresponding to heme. (g) LESA
MS image of ions with m/z 857.3743 corresponding to ubiquitin (+10 charge state). (h) LESA MS image of ions with m/z 394.1773 corresponding
to [M + H]+ ions of erlotinib.
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found that a LESA solvent system comprising 70% MeOH, 1%
formic acid is suitable for the simultaneous analysis of singly
charged small molecules, multiply charged protein species, and
the drug compound erlotinib, which was detected with m/z
394.1773 corresponding to [M + H]+ ions.
The spacing between LESA sampling locations was deﬁned
as 1 mm, the minimum distance permitted by LESA Points
software. The sampling routine used to acquire this data set was
modiﬁed to minimize solvent spreading and allow for greater
sampling precision; the method has previously been termed
“contact” LESA.2 The method involves bringing the sampling
pipette into contact with the sample surface prior to solvent
dispensation and an assumption that the solvent is entirely
contained within the pipette tip during sampling“plugged” by
the sample itself. Optical images of the tissue section after
“noncontact” (in which only the solvent was allowed to come
into contact with the surface, all other sampling parameters
remained the same) and “contact” LESA sampling demonstrate
a decrease in relative size of area sampled (spot diameter
decreased from ∼1158 to ∼690 μm), see Supporting
Information Figure 1. These images also highlight unsampled
regions of tissue which result from sample spacing of 1 mm and
sampling diameter of less than 1 mm. Reliability of sampling
was found to be improved using contact LESA because there
was no requirement for formation of a stable liquid micro-
junction. Sampling precision was also found to be improved
using contact LESA; the pipette tip walls prevent solvent
droplet spreading to the same extent observed during normal
LESA sampling, although some spreading beyond the expected
contact area of the pipette tip is still observed. Aspects of
sampling reliability and precision will be further discussed
below.
Post-LESA MALDI MS Imaging. After the sample had
been imaged by LESA MS, both this section and a serial section
placed adjacent on the slide were coated with matrix and
imaged using MALDI MS. There were several reasons for doing
this: to provide higher resolution tissue images which
complement the LESA MS data, to establish whether
performing LESA prior to MALDI in a multimodal workﬂow
is feasible (i.e., to determine whether MALDI image integrity is
maintained), and to ascertain whether higher resolution
MALDI MS images can be used to better understand LESA
sampling. The adjacent tissue section served as a control and
allowed changes induced by LESA sampling to be assessed.
The MALDI MSI method was optimized for lipid analysis;
an example single-pixel spectrum from the tissue section which
had not been sampled by LESA is displayed in Figure 2a. A
number of lipid species were detected in the m/z range of 600−
900; an example ion image (tentatively assigned as PC 36:1)
can also be seen in Figure 2a. The lipids were preferentially
detected as the potassium adduct. Ions detected at m/z’s
corresponding to the sodium adduct and protonated molecule
were also observed but with a lower intensity. In these images it
is possible to see the regions which were sampled by LESA.
These features are generally classiﬁed by a region of higher ion
intensity surrounded by a dark ring in which very few ions were
detected. These features were not observed in the control
image. It would appear that LESA sampling acts as a localized
tissue wash, enhancing lipid detection via the extraction of
analyte to the tissue surface and extraction and washing of salts
resulting in a concentration gradient, highest at the edge of the
spot. The region of tissue which was spiked with erlotinib
solution appears as a similar although larger feature in the
image. This supports the theory that analyte extraction, rather
Figure 2. MALDI MS imaging of tissue after LESA sampling: (a) Left, example single-pixel spectrum, peaks in the m/z range of 700−900
correspond to lipid ions; right, MALDI MS image of ions with m/z 826.6, tentatively assigned as [M + K]+ ions of PC 36:1; blue circle indicates the
region spiked with erlotinib solution. (b) Left, overlaid MALDI MS ion images of protonated and potassium adduct of PC 36:1; right, overlaid
intensity line proﬁles across the center of one LESA-sampled region; plot in pink corresponds to [M + H]+ ion intensity which peaks sharply towards
the center of the spot; plot in green corresponds to [M + K]+ ions which are more homogeneously distributed across the spot.
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than mitigation of suppression eﬀects, is responsible for the
observed intensity increase because the spiked solution was
allowed to remain on the tissue and therefore did not remove
any dissolved species. To further probe the distribution of lipid
species across the LESA-sampled area, a composite ion image
of the protonated and potassiated molecules of PC 36:1 was
generated, and intensity line proﬁles across a single LESA spot
were plotted, see Figure 2b. It was found that [M + H]+ ions
were preferentially detected towards the center of the LESA-
sampled area, whereas [M + K]+ ions were more abundant
towards the outside or homogeneously distributed across the
spot. This behavior was also observed for a number of other
lipid species. This is presumably caused by solvent washing salts
towards the edge of the sampled area and depositing larger
amounts at the outer perimeter as the residual solvent on the
surface dries postsampling. Accumulation of salt at this outer
perimeter could also be responsible for the “dark ring” observed
in MALDI MS lipid images; matrix crystals exhibit diﬀerent
morphology when formed from solution containing diﬀerent
proportions of salts.6 Optical images of a LESA-sampled tissue
section before and after coating with matrix are displayed in
Figure 3, parts a and b. The regions sampled by LESA appear as
darker regions compared to unsampled tissue; a circular imprint
can be observed in the middle of this region which results from
the pipette tip coming into contact with the tissue. A larger,
more irregular dark region surrounds this mark, which suggests
the solvent spread further than the conﬁnes of the pipette tip.
An experiment in which contact LESA was performed without
any solvent conﬁrmed that solvent washing eﬀects and not
compression or damage of the tissue during contact were
responsible for the observed intensity changes in MALDI
images, see Supporting Information Figure 2. The image
displayed in Figure 3b demonstrates the size and distribution of
CHCA crystals on the tissue surface after matrix coating. A
region of sparse, thin crystals can be seen around the outer
edges which correspond with the dark region of the ion image
displayed in Figure 3d, suggesting that changes to matrix
morphology resulting in poor analyte inclusion and subsequent
ablation/ionization are responsible for low ion counts from this
region. An example MALDI MS image (m/z 826.6) overlaid
with the optical image demonstrates that regions of higher
intensity in the ion image correspond with darker regions
observed in the optical image, see Figure 3c.
MALDI MS ion images reveal details about locations, size,
and variation of LESA-sampled areas. Previous work has relied
on optical images alone to provide this information, whereas we
now present mass spectral data which veriﬁes that visual
changes to the tissue correspond with spectral changes
indicative of solvent contact. Additionally, dislocation, leaching,
and other changes in analyte distribution within the sampled
area (which appears as a homogeneous area in the optical
image) can be visualized using MALDI MSI. Two MALDI MSI
data sets were obtained from tissue sampled by LESA, with
pixel sizes of 100 and 50 μm, respectively. While no further
features could be observed with the increased image detail
aﬀorded by 50 μm pixels, the outer limits of the sampled region
could be more accurately deﬁned. As such, MALDI MS images
with 50 μm pixels were used to take measurements. The
average area sampled per contact LESA spot is 0.41 mm2.
Diﬀerences in size of these areas is caused either by diﬀering
degrees of solvent spreading during sampling or diﬀering
volumes of residual solvent left on the tissue after LESA
sampling, or some combination of both. The distance between
these areas in x and y dimensions varies considerably, as
Figure 3. (a) Optical image of tissue section after LESA MS; darker regions indicate solvent contact with tissue; the smaller circle in the middle of
the dark region is caused by imprint of the pipette tip. (b) Optical image of LESA-sampled region after coating with CHCA matrix; the lighter region
at the perimeter of the LESA spot indicates thinner crystal layer. (c) Overlaid MALDI MS image of ions with m/z 826.6 and optical image. (d)
Enlargement of MALDI MS image of ions with m/z 826.6 to show the same LESA-sampled region as displayed in panel b; the dark region in the ion
image corresponds with the thinner region of matrix crystals in the optical image.
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indicated by images in Figure 3. In order to maximize the total
surface sampled by LESA in an imaging experiment, individual
samples should be taken next to each other with as small a gap
between them as possible but without overlapping (this would
result in oversampling which, although common practice in
MALDI MSI, is inappropriate for LESA MS because signal can
be acquired multiple times from the same location). The
spacing required between points for maximum coverage using
Figure 4. Results from multivariate analysis: (a−c) Score images of principal components 1, 5, and 6, respectively; principal component 1 indicates
that the greatest variance is between tissue and background, principal component 5 indicates variance between LESA-sampled areas and the rest of
the tissue, and principal component 6 indicates that LESA-sampled regions on white matter are more diﬀerent from the original tissue type than
those from grey matter. (d) k-Means clustering (k = 7) on masked image to remove background; the same clusters corresponding to anatomical
features within the tissue are found in both LESA-sampled tissue and the control section indicating that LESA only induced localized changes; these
are identiﬁed as diﬀerent clusters in grey and white matter; further clusters identify the outer perimeter of LESA-sampled regions. (e) t-SNE reveals
the same clusters identifying diﬀerent tissue anatomies in LESA-sampled tissue and control tissue; LESA-sampled regions are assigned diﬀerent
clusters depending on the original type of tissue; however, these are more similar to each other than the original type of tissue; the region where the
drug was spiked is also similar to the LESA-sampled regions but more similar to the original tissue type presumably because the solvent was not
removed from the tissue and therefore did not deplete the tissue in the same way. (f−h) Examples of three factors identiﬁed by NMF, their spatial
distributions, and contributing spectral components.
Analytical Chemistry Article
DOI: 10.1021/acs.analchem.5b04281
Anal. Chem. 2016, 88, 8433−8440
8438
contact LESA would be ∼700 μm, providing sampling spatial
precision was accurate. However, MALDI MSI images reveal
that intersample distances (measured from center to center)
vary between 0.8 and 1.3 mm. Accurate determination of these
variations is important in furthering LESA MS as an imaging
technique.
In order to fully assess changes between the LESA-sampled
section and serial control it is necessary to consider variation
within the whole spectrum, as well as individual m/z channels.
This also aids in interpretation of MALDI data obtained after
LESA sampling. Complementary multivariate analysis techni-
ques were applied to the data in order to study the eﬀects of
LESA sampling. PCA score images are displayed in Figure 4a−c
and can be used to identify sources of variance within the data.
The largest source of variance in the data set is the diﬀerence
between tissue and background, shown by principal component
1. Principal component 5 shows the “halo” region, a common
feature of MALDI MSI experiments. Principal component 6
identiﬁes LESA sampling regions, where the regions sampled
on areas of white matter are more intense than those on grey
matter. This is interesting because it suggests that changes
associated with LESA sampling do not appear uniformly across
the tissue. This has implications for any sample preparation
procedures which undergo a wash step because it implies that
inhomogeneous washing occurs across the tissue and therefore
false contrast could be introduced in ion images. Thresholded
PCA score images, principal component 1 (matrix region), and
principal component 5 (“halo” region) shown in Figure 4, parts
a and b, respectively, were used to generate a mask to segment
the background from the tissue for further multivariate analysis.
k-Means clustering was applied to the PCA-reduced data set to
identify pixels with similar spectral proﬁles and label them with
a randomly assigned color, see Figure 4d. k-Means clustering
successfully separated the diﬀerent brain anatomies and LESA-
sampled regions on white and grey brain tissue. The results
from this analysis are easy to interpret and demonstrate
agreement with individual lipid ion images. Two clusters are
identiﬁed which are unique to the LESA-sampled tissue section
and are labeled red and pale blue in Figure 4d. Clustering, with
the parameters used, does separate the outer perimeter of these
regions into a unique cluster. In general, k-means clustering
provides no visual indication of how spectrally similar the
identiﬁed clusters are. t-Distributed stochastic neighbor
embedding (t-SNE) is a dimensionality reduction technique
which has been used in MSI for visualization of complex data
sets.23 The color of each pixel is related to its location in the
reduced space, thus providing a visual indication of how similar
two pixels are spectrally. When applied to this data set, t-SNE
reveals very similar results for control tissue and unsampled
regions of section sampled by LESA. The regions sampled by
LESA appear signiﬁcantly diﬀerent to the unsampled regions,
with slight diﬀerences observable depending on whether the
sampled region was grey or white matter, see Figure 4e.
Although this data visualization approach is useful in identifying
regions of spectral similarity and gradients of change aﬀected by
LESA sampling, no spectral information about the diﬀerent
regions is provided, and therefore, it is hard to identify which
spectral features have contributed. Non-negative matrix
factorization (NMF) decomposes the data into a set of unique
spatial distributions and associated spectral proﬁles. NMF
applied to this data set identiﬁes a number of spatial
distributions arising from LESA sampling, see Figure 4f−h.
The image in Figure 4f identiﬁes a distribution corresponding
to white matter in the tissue sections. Major m/z values
contributing to this distribution are 798 and 826, which are
tentatively assigned as the potassium adducts of PC 34:1 and
PC 36:1, respectively, i.e., the most abundant lipid species
detected from mouse brain tissue. The image in Figure 4g
identiﬁes regions at the center of the LESA-sampled regions;
examination of individual ion images revealed that protonated
molecules of lipids were detected with higher intensity here.
Peaks with m/z 760 and 788 (tentatively assigned as
protonated molecules of PC 34:1 and PC 36:1, respectively)
are identiﬁed by NMF as major contributors to this
distribution, supporting conclusions drawn from manual
analysis.
It was found that features introduced into some MALDI MS
ion images can be largely removed via total intensity
normalization, see Supporting Information Figure 3. For
other ion images this normalization strategy is less successful,
see Supporting Information Figure 3. This is to be expected
based on asserted changes to distribution of lipid adducts. An
understanding of MALDI mass spectral changes associated with
LESA sampling could help inform more sophisticated and
appropriate normalization methods; for example, factors
identiﬁed by NMF could be used to correct for changes in
intensity and distribution.
■ CONCLUSION
We have presented a combined workﬂow which exploits the
combined advantages of LESA and MALDI MSI and
additionally provides insight into aspects of ambient surface
sampling. LESA provided sensitive analysis of multiple classes
of analyte simultaneously with spatial information. MALDI
provided high spatial resolution images which detailed the
anatomical features within tissue which were too small for
LESA to successfully resolve. MALDI images were also used to
accurately deﬁne the exact locations sampled by LESA, their
size, and variation. Importantly, LESA does not appear to blur
or distort anatomical features. Several multivariate techniques
were employed to assess changes to distribution induced by
LESA. Future implementations of MALDI MSI after LESA
analysis could assess diﬀerent washing protocols, or how the
same wash aﬀects diﬀerent regions of tissue. This could also be
used to assess improvements or changes made to the
automated LESA sampling routines described here, for
example, to determine the spacing of sampled areas and ensure
that no oversampling had occurred. LESA MS is somewhat
limited as an imaging technique by the poor spatial resolution it
aﬀords; however, there are opportunities for further decreasing
pixel size via contact LESA and smaller sampling pipette tips.
As the technique improves in terms of sampling precision and
repeatability, combining it with MALDI will become an even
more attractive option. The potential for inclusion of standards
by LESA is also attractive, and provides possible routes towards
quantitative analysis. The combined LESA−MALDI MSI
workﬂow could then be applied to drug in tissue studies
which could provide quantitative analysis of drug/lipid/protein
via LESA and a higher spatial resolution reference in MALDI
MS images.
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